Respiratory Syncytial Virus
-
Study finds RSV may evade vaccines via rapid mutation
A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. Read MoreMar 9, 2023
-
RSV transmission in the Middle East
Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design. Read MoreNov 14, 2019
-
Hope for an RSV vaccine
Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design. Read MoreFeb 23, 2018
-
RSV-HRV viral interference
RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants. Read MoreMay 15, 2017
-
Research sheds light on how RSV wards off potential vaccines
Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it. Read MoreOct 20, 2016
-
Study finds maternal diet may predict RSV severity
An important predictor of the severity of respiratory syncytial virus (RSV) in infants may be what their mothers ate during pregnancy. Read MoreMar 4, 2013